ArticleJournal of immunology research2021

Pan-Cancer Analyses of the Tumor Microenvironment Reveal That Ubiquitin-Conjugating Enzyme E2C Might Be a Potential Immunotherapy Target.

Guang-Zhao Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.